PCSK9 and inherited lipid metabolism disorder: A direct effect of PCSK9 on platelets independent of its effects on dyslipidaemia has been recently shown as PCSK9 inhibitors can enhance oxidative stress (as a result of the activation of the Nox2 and cPLA2 signaling cascades) and block platelet activation in Wt human platelets (108).